Adeona Pharmaceuticals, Inc. (AEN) Signs Manufacturing Agreement with TG United
Today, Adeona Pharmaceuticals, Inc., a developer of innovative medicines used in the treatment of serious central nervous system diseases, announced that it has executed an agreement with TG United, Inc. of Brooksville, FL, to provide commercial-scale manufacturing capabilities for reaZin. reaZin is Adeona’s product candidate for the dietary management of Alzheimer’s disease and mild cognitive impairment, as a prescription medical food. The company is currently focusing on further developing this product. Results from Adeona’s clinical study evaluating reaZin were presented last week at the 63rd Annual Meeting of the American Academy of Neurology. The primary outcome of increasing serum zinc…